❌

Normal view

Received — 15 September 2026 ⏭

Membership Inference Attacks on Recommender System: A Survey

✇cs.AI, q-bio.NC updates on arXiv.org
By: Jiajie He · Xintong Chen · Xinyang Fang · Min-Chun Chen · Yuechun Gu · Wenjin Liu · Keke Chen
14 September 2026 at 12:00
arXiv:2509.11080v4 Announce Type: replace-cross Abstract: Recommender systems (RecSys) have been widely applied to various applications, including E-commerce, finance, healthcare, social media and have become increasingly influential in shaping user behavior and decision-making, highlighting their growing impact in various domains. However, recent studies have shown that RecSys are vulnerable to membership inference attacks (MIAs), which aim to infer whether user interaction record was used to train a target model or not. MIAs on RecSys models can directly lead to a privacy breach. For example, via identifying the fact that a purchase record that has been used to train a RecSys associated with a specific user, an attacker can infer that user's special quirks. In recent years, MIAs have been shown to be effective on other ML tasks, e.g., classification models and natural language processing. However, traditional MIAs are ill-suited for RecSys due to the unseen posterior probability. Although MIAs on RecSys form a newly emerging and rapidly growing research area, there has been no systematic survey on this topic yet. In this article, we conduct the first comprehensive survey on RecSys MIAs. This survey offers a comprehensive review of the latest advancements in RecSys MIAs, exploring the design principles, challenges, attack and defense associated with this emerging field. We provide a unified taxonomy that categorizes different RecSys MIAs based on their characterizations and discuss their pros and cons. Based on the limitations and gaps identified in this survey, we point out several promising future research directions to inspire the researchers who wish to follow this area. This survey not only serves as a reference for the research community but also provides a clear description for researchers outside this research domain.
Received — 10 September 2026 ⏭

Early stage nonsmall cell lung cancer: Toward a risk-adaptive paradigm in the era of biologic precision

✇Omics In Lung
By: Chaoqi Zhang · Xuanyu Gu · Pan Wang · Dongyu Li · Guochao Zhang · Ting Wang · Peng Wu · Wei Rao · Shan Muhammad · Binghua Tan · Yun Che · Mobai Zhu · Qilin Qiao · Fanbo Lai · Bohui Zhao · Kailun Fei · Yue Wu · Zhihui Zhang · Min Dai · Wanqing Chen · Yawei Zhang · Nan Bi · Jie Wang · Jie He
9 September 2026 at 18:00

CA Cancer J Clin. 2026 Sep-Oct;76(5):e70100. doi: 10.3322/caac.70100.

ABSTRACT

The clinical landscape of early stage nonsmall cell lung cancer is at transformative crossroads. Driven by the widespread adoption of low-dose computed tomography screening, the frequent detection of ground-glass opacities, and a rising incidence among never-smokers, the diagnostic center of gravity has shifted toward earlier, potentially curable disease. This shift has been accompanied by equally important therapeutic advances, including parenchyma-sparing surgical techniques, minimally invasive platforms enhanced by digital navigation, and the transformative integration of perioperative immunotherapy and targeted agents. Concurrently, noninvasive monitoring approaches, such as liquid biopsy, have emerged as powerful tools to guide precision management. Despite this progress, substantial barriers to achieving a universal cure persist. Clinicians continue to face uncertainty in the management of ground-glass opacities, the anatomy-based TNM staging system fails to capture the biologic heterogeneity of early tumors, and global disparities in access to innovation remain unresolved. To address these challenges, the authors propose a shift toward a risk-adaptive management paradigm that harnesses artificial intelligence-driven analytics and multi-omics profiling to tailor treatment intensity according to each patient's biologic risk. Such an approach would enable appropriate escalation for high-risk individuals while permitting safe de-escalation for those at low risk. This holistic, lifespan-oriented strategy must be embraced to deliver equitable and durable cures for patients with early stage nonsmall cell lung cancer.

PMID:42713910 | PMC:PMC13555834 | DOI:10.3322/caac.70100

Early stage nonsmall cell lung cancer: Toward a risk-adaptive paradigm in the era of biologic precision

✇(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)
By: Chaoqi Zhang · Xuanyu Gu · Pan Wang · Dongyu Li · Guochao Zhang · Ting Wang · Peng Wu · Wei Rao · Shan Muhammad · Binghua Tan · Yun Che · Mobai Zhu · Qilin Qiao · Fanbo Lai · Bohui Zhao · Kailun Fei · Yue Wu · Zhihui Zhang · Min Dai · Wanqing Chen · Yawei Zhang · Nan Bi · Jie Wang · Jie He
9 September 2026 at 18:00

CA Cancer J Clin. 2026 Sep-Oct;76(5):e70100. doi: 10.3322/caac.70100.

ABSTRACT

The clinical landscape of early stage nonsmall cell lung cancer is at transformative crossroads. Driven by the widespread adoption of low-dose computed tomography screening, the frequent detection of ground-glass opacities, and a rising incidence among never-smokers, the diagnostic center of gravity has shifted toward earlier, potentially curable disease. This shift has been accompanied by equally important therapeutic advances, including parenchyma-sparing surgical techniques, minimally invasive platforms enhanced by digital navigation, and the transformative integration of perioperative immunotherapy and targeted agents. Concurrently, noninvasive monitoring approaches, such as liquid biopsy, have emerged as powerful tools to guide precision management. Despite this progress, substantial barriers to achieving a universal cure persist. Clinicians continue to face uncertainty in the management of ground-glass opacities, the anatomy-based TNM staging system fails to capture the biologic heterogeneity of early tumors, and global disparities in access to innovation remain unresolved. To address these challenges, the authors propose a shift toward a risk-adaptive management paradigm that harnesses artificial intelligence-driven analytics and multi-omics profiling to tailor treatment intensity according to each patient's biologic risk. Such an approach would enable appropriate escalation for high-risk individuals while permitting safe de-escalation for those at low risk. This holistic, lifespan-oriented strategy must be embraced to deliver equitable and durable cures for patients with early stage nonsmall cell lung cancer.

PMID:42713910 | DOI:10.3322/caac.70100

Received — 8 April 2026 ⏭

Initial Insights Into an Institutional Secure Large Language Model for Magnetic Resonance Imaging Examination Requests: Retrospective Study

✇Journal of Medical Internet Research
By: James Thomas Patrick Decourcy Hallinan · Naomi Wenxin Leow · Yi Xian Low · Aric Lee · Wilson Ong · Matthew Ding Zhou Chan · Ganakirthana Kalpenya Devi · Stephanie Shengjie He · Daniel De-Liang Loh · Desmond Shi Wei Lim · Xi Zhen Low · Mei Chin Lim · Clement Yong · Weizhong Jonathan Sng · Ee Chin Teo · Jiong Hao Tan · Naresh Kumar · Andrew Makmur · Yonghan Ting
8 April 2026 at 01:30
Background: Incomplete clinical details on magnetic resonance imaging (MRI) examination requests (MERs) can lead to suboptimal protocol selection. An institutional secure large language model (sLLM) with access to manually retrieved salient data from the electronic medical record (EMR) may improve request completeness and protocol accuracy across multiple MRI subspecialties. Objective: The objective of this study was to compare clinician MERs with sLLM-augmented MERs for information quality and to evaluate the protocoling accuracy of the sLLM versus board-certified radiologists across body, musculoskeletal, and neuroradiology MRI. Methods: This retrospective study included 608 random outpatient MRI examinations performed between September 2023 and July 2024 (body 206, musculoskeletal 203, neuroradiology 199). The cohort comprised 528 patients (mean 51.2 years, SD 19.2; range 4‐93; n=279, 52.8% women, n=249, 47.2% men). MERs without EMR access were excluded. A privately hosted Anthropic Claude 3.5 model (temperature 0) augmented each MER with manually retrieved salient EMR data and, via rule-based parsing, mapped the extracted elements onto predefined institutional criteria to recommend region or coverage and contrast use. Two experienced radiologists established a consensus reference standard. Two board-certified general radiologists (Rad 3 and Rad 4) and the sLLM were compared with this standard. Clinical information quality was graded using the Reason-for-Exam Imaging Reporting and Data System (RI-RADS). Interrater reliability was quantified with Gwet AC1. Paired accuracies were compared with the McNemar test to determine whether there was a statistically significant difference. Results: Interreader agreement for RI-RADS was almost perfect for sLLM-augmented MERs (AC1 0.97, 95% CI 0.94‐0.99) and moderate for clinician MERs (AC1 0.43, 95% CI 0.34‐0.52). Limited or deficient clinical information (RI-RADS C/D) fell to 0% to 0.7% (0/608 to 4/608) with sLLM augmentation vs 4.1% to 20.4% (25/608 to 124/608) for clinician MERs. Overall protocol accuracy was 93.1% (566/608; 95% CI 89.6‐96.6) for the sLLM, 91.4% (556/608; 95% CI 87.6‐95.3) for Rad 3, and 92.1% (560/608; 95% CI 88.4‐95.8) for Rad 4 (sLLM vs Rad 3 =.23 vs Rad 4 =.40). Region or coverage accuracy was similar (sLLM: 579/608, 95.2%; Rad 3: 585/608, 96.2%; Rad 4: 573/608, 94.2%; =.46 and =.36). Contrast decisions were more accurate using the sLLM at 94.4% (574/608; 95% CI 91.3‐97.5) vs Rad 3 at 92.1% (560/608; 95% CI 88.4‐95.8; =.027) and were not significantly different to Rad 4 at 92.9% (565/608; 95% CI 89.4‐96.4; =.16). Subspecialty analyses showed similar patterns, with the sLLM outperforming Rad 4 for musculoskeletal MRI contrast decisions (96.6% vs 91.1%; =.006) and matching readers elsewhere. Manual review indicated that sLLM improvements arose from EMR details not listed on the MER (infection/inflammation, tumor history, prior surgery). No clinically significant hallucinations were identified in a manual review of discordant cases. Conclusions: Across body, musculoskeletal, and neuroradiology MRI, sLLM-augmented examination requests improved clinical context and enhanced contrast selection while demonstrating accuracy comparable to general radiologists for region or coverage. Integrating sLLMs into routine vetting workflows may reduce manual workload in protocol selection for more efficient, standardized protocoling.
Received — 26 March 2026 ⏭

3DCity-LLM: Empowering Multi-modality Large Language Models for 3D City-scale Perception and Understanding

✇cs.AI, q-bio.NC updates on arXiv.org
By: Yiping Chen · Jinpeng Li · Wenyu Ke · Yang Luo · Jie Ouyang · Zhongjie He · Li Liu · Hongchao Fan · Hao Wu
25 March 2026 at 12:00
arXiv:2603.23447v1 Announce Type: cross Abstract: While multi-modality large language models excel in object-centric or indoor scenarios, scaling them to 3D city-scale environments remains a formidable challenge. To bridge this gap, we propose 3DCity-LLM, a unified framework designed for 3D city-scale vision-language perception and understanding. 3DCity-LLM employs a coarse-to-fine feature encoding strategy comprising three parallel branches for target object, inter-object relationship, and global scene. To facilitate large-scale training, we introduce 3DCity-LLM-1.2M dataset that comprises approximately 1.2 million high-quality samples across seven representative task categories, ranging from fine-grained object analysis to multi-faceted scene planning. This strictly quality-controlled dataset integrates explicit 3D numerical information and diverse user-oriented simulations, enriching the question-answering diversity and realism of urban scenarios. Furthermore, we apply a multi-dimensional protocol based on text-similarity metrics and LLM-based semantic assessment to ensure faithful and comprehensive evaluations for all methods. Extensive experiments on two benchmarks demonstrate that 3DCity-LLM significantly outperforms existing state-of-the-art methods, offering a promising and meaningful direction for advancing spatial reasoning and urban intelligence. The source code and dataset are available at https://github.com/SYSU-3DSTAILab/3D-City-LLM.

SIRT3 deacetylates STEAP4 to modulate cuproptosis sensitivity via mitochondrial metabolic reprogramming in HBV-related HCC

✇Omics in Hepatocellular
By: Ze-Bang Du · Xin-Mou Wu · Jia-Ming Lei · Yu-Xin Cai · Jie He · Bo Qian · Xin-Xin He · Wen-Hao Han · Yuan Lu · Xiao-Gang Xia · Han-Ying Zheng · Dong-Bei Guo · You-Liang Yao · Wen-Gang Li · Yu-Chun Lin · Zhong-Ning Lin
17 March 2026 at 18:00

Cell Death Differ. 2026 Mar 16. doi: 10.1038/s41418-026-01713-w. Online ahead of print.

ABSTRACT

Hepatitis B virus (HBV) infection remains a leading etiological driver of hepatocellular carcinoma (HCC). Cuproptosis is a recently defined copper-dependent form of regulated cell death that selectively eliminates mitochondria-dependent cells; whether HBV rewires this vulnerability remains unknown. Here we unveil a novel HBV X protein (HBx)-driven mechanism of cuproptosis evasion. Integrative analysis of clinical specimens, HBx-transgenic (HBx-Tg) mice, and multi-omics datasets revealed marked downregulation of STEAP4 (six-transmembrane epithelial antigen of prostate 4), a metalloreductase essential for cuproptosis sensitivity, in HBV-positive HCC. Mechanistically, HBx attenuates sirtuin 3 (SIRT3), impairing deacetylation of STEAP4 at lysine 404 and abolishing its mitochondrial targeting. Consequently, cells switch from the tricarboxylic acid (TCA) cycle respiration to glycolysis, reducing sensitivity to the copper ionophore elesclomol (ES). Restoring STEAP4 expression or pharmacological activation of SIRT3 with honokiol (HKL) re-instated mitochondrial STEAP4 localization and re-sensitized HBV-related HCC cells to cuproptosis; combination with ES produced synergistic tumor suppression in vitro and in orthotopic models. Collectively, our findings establish the SIRT3-STEAP4 axis as a novel regulator of cuproptosis resistance in HBV-related HCC. HBx-mediated repression of SIRT3 disrupts STEAP4 deacetylation and mitochondrial targeting, fostering metabolic reprogramming and evasion of copper-induced cell death. The results provide a pre-clinical rationale for copper-directed combination strategies in HBV-associated HCC.

PMID:41840161 | DOI:10.1038/s41418-026-01713-w

Received — 5 March 2026 ⏭

PROSPECT: Unified Streaming Vision-Language Navigation via Semantic--Spatial Fusion and Latent Predictive Representation

✇cs.AI, q-bio.NC updates on arXiv.org
By: Zehua Fan · Wenqi Lyu · Wenxuan Song · Linge Zhao · Yifei Yang · Xi Wang · Junjie He · Lida Huang · Haiyan Liu · Bingchuan Sun · Guangjun Bao · Xuanyao Mao · Liang Xu · Yan Wang · Feng Gao
5 March 2026 at 13:00
arXiv:2603.03739v1 Announce Type: cross Abstract: Multimodal large language models (MLLMs) have advanced zero-shot end-to-end Vision-Language Navigation (VLN), yet robust navigation requires not only semantic understanding but also predictive modeling of environment dynamics and spatial structure. We propose PROSPECT, a unified streaming navigation agent that couples a streaming Vision-Language-Action (VLA) policy with latent predictive representation learning. PROSPECT uses CUT3R as a streaming 3D foundation spatial encoder to produce long-context, absolute-scale spatial features, and fuses them with SigLIP semantic features via cross-attention. During training, we introduce learnable stream query tokens that query the streaming context and predict next-step 2D and 3D latent features (rather than pixels or explicit modalities), supervised in the latent spaces of frozen SigLIP and CUT3R teachers. The predictive branch shapes internal representations without inference overhead. Experiments on VLN-CE benchmarks and real-robot deployment demonstrate state-of-the-art performance and improved long-horizon robustness under diverse lighting. We will release code for the community soon.

Skywork-Reward-V2: Scaling Preference Data Curation via Human-AI Synergy

✇cs.AI, q-bio.NC updates on arXiv.org
By: Chris Yuhao Liu · Liang Zeng · Yuzhen Xiao · Jujie He · Jiacai Liu · Chaojie Wang · Rui Yan · Wei Shen · Fuxiang Zhang · Jiacheng Xu · Yang Liu · Yahui Zhou
4 March 2026 at 13:00
arXiv:2507.01352v3 Announce Type: replace-cross Abstract: Despite the critical role of reward models (RMs) in Reinforcement Learning from Human Feedback (RLHF), current state-of-the-art open RMs perform poorly on most existing evaluation benchmarks, failing to capture nuanced human preferences. We hypothesize that this brittleness stems primarily from limitations in preference datasets, which are often narrowly scoped, synthetically labeled, or lack rigorous quality control. To address these challenges, we present SynPref-40M, a large-scale preference dataset comprising 40 million preference pairs. To enable data curation at scale, we design a human-AI synergistic two-stage pipeline that leverages the complementary strengths of human annotation quality and AI scalability. In this pipeline, humans provide verified annotations, while LLMs perform automatic curation based on human guidance. Training on this preference mixture, we introduce Skywork-Reward-V2, a suite of eight reward models ranging from 0.6B to 8B parameters, trained on a carefully curated subset of 26 million preference pairs from SynPref-40M. We demonstrate that Skywork-Reward-V2 is versatile across a wide range of capabilities, including alignment with human preferences, objective correctness, safety, resistance to stylistic biases, and best-of-N scaling. These reward models achieve state-of-the-art performance across seven major reward model benchmarks, outperform generative reward models, and demonstrate strong downstream performance. Ablation studies confirm that effectiveness stems not only from data scale but also from high-quality curation. The Skywork-Reward-V2 series represents substantial progress in open reward models, demonstrating how human-AI curation synergy can unlock significantly higher data quality.
There are no more articles
❌